Najit Technologies, Inc.
Clinical trials sponsored by Najit Technologies, Inc., explained in plain language.
-
New chikungunya vaccine shows promise in early trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine called HydroVax-005 CHIKV to see if it is safe and helps the body fight chikungunya virus, a mosquito-borne disease that causes fever and joint pain. The trial involved 48 healthy adults aged 18 to 49 who received two shots of either a low or high …
Phase: PHASE1 • Sponsor: Najit Technologies, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 10:13 UTC
-
New yellow fever vaccine passes early safety check in small trial
⭐️ VACCINE ⭐️ CompletedThis early-stage trial tested a new inactivated yellow fever vaccine called HydroVax-002 YFV in 26 healthy adults aged 18 to 49. Participants received two shots of either a low or high dose of the vaccine or a placebo, given one month apart. The main goal was to check safety and …
Phase: PHASE1 • Sponsor: Najit Technologies, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 20, 2026 11:54 UTC